Systemic and ocular risks associated with therapies for macular degeneration: clarification vs confusion

MLA

Thomas R. Friberg, et al. “Systemic and Ocular Risks Associated with Therapies for Macular Degeneration: Clarification vs Confusion.” Archives of Ophthalmology (Chicago, Ill. : 1960), vol. 130, no. 6, July 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26e82a0f5037fcd995f7e4e44abd0f53&authtype=sso&custid=ns315887.

APA

Thomas R. Friberg, Richard A. Bilonick, & Veeral Shah. (2012). Systemic and ocular risks associated with therapies for macular degeneration: clarification vs confusion. Archives of Ophthalmology (Chicago, Ill. : 1960), 130(6).

Chicago

Thomas R. Friberg, Richard A. Bilonick, and Veeral Shah. 2012. “Systemic and Ocular Risks Associated with Therapies for Macular Degeneration: Clarification vs Confusion.” Archives of Ophthalmology (Chicago, Ill. : 1960) 130 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26e82a0f5037fcd995f7e4e44abd0f53&authtype=sso&custid=ns315887.